Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Edgewise Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Edgewise Therapeutics Inc. June 4, 202670.3%
-
Edgewise Therapeutics Inc. June 9, 202376.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Option exercise | +13,690 | $0.39 | $5,339 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Option exercise | +17,236 | $0.64 | $11,031 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Option exercise | +10,463 | $1.93 | $20,194 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Option exercise | +66,477 | $1.93 | $128,301 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Option exercise | +7,605 | $0.71 | $5,400 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −13,690 | $29.44 | $403,034 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −17,236 | $29.44 | $507,428 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −7,605 | $29.44 | $223,891 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −10,463 | $29.44 | $308,031 |
| Jan 21, 2026 | Edgewise Therapeutics Inc. | Open-market sale | −66,477 | $29.44 | $1,957,083 |
Questions about Badreddin Edris
What boards is Badreddin Edris on?
Badreddin Edris sits on the board of Edgewise Therapeutics Inc.
How long has Badreddin Edris served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.